AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16014845 — intervention group
Group type: EXPERIMENTAL
Intervention: DEC/ALB
Number of subjects: 0
Study 16014845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16014845 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC)
Number of subjects: 0
Study 12442883 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride (200-800 mg/d)
Number of subjects: 377
Study 12442883 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine (5-20 mg/d)
Number of subjects: 377
Study 10193779 — intervention group
Group type: EXPERIMENTAL
Intervention: TASP-V (10 microg kg(‐1) intranasal pretreatment)
Number of subjects: 20
Study 10193779 — intervention group
Group type: EXPERIMENTAL
Intervention: TASP-V analogue (10 microg kg(‐1) aerosolized pretreatment)
Number of subjects: 20
Study 10193779 — intervention group
Group type: EXPERIMENTAL
Intervention: TASP-V analogue (20 microg kg(‐1) aerosolized pretreatment)
Number of subjects: 20
Study 10193779 — intervention group
Group type: EXPERIMENTAL
Intervention: TASP-V (1.275 microg kg(‐1) intranasal pretreatment)
Number of subjects: 20
Study 10193779 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study 7738436 — intervention group
Group type: EXPERIMENTAL
Intervention: Colored overlays or lenses (e.g., Irlen lenses)
Number of subjects: 8
Study 7738436 — intervention group
Group type: COMPARATOR
Intervention: Clear and chromatic lenses
Number of subjects: 8
Study 2405616 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (20 mg three times daily)
Number of subjects: 250
Study 2405616 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (30 mg three times daily)
Number of subjects: 250
Study 6107945 — intervention group
Group type: EXPERIMENTAL
Intervention: DL-308 (10 mg)
Number of subjects: 8
Study 6107945 — intervention group
Group type: EXPERIMENTAL
Intervention: DL-308 (20 mg)
Number of subjects: 8
Study 6107945 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine (50 mg)
Number of subjects: 8
Study 6107945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6107945 — intervention group
Group type: EXPERIMENTAL
Intervention: DL-308 (10 mg) vs Thioridazine (50 mg)
Number of subjects: 8
Study 6107945 — intervention group
Group type: EXPERIMENTAL
Intervention: DL-308 (10 mg) and Thioridazine (50 mg)
Number of subjects: 8
Study 6107945 — intervention group
Group type: EXPERIMENTAL
Intervention: DL-308 and Thioridazine
Number of subjects: 8
Study 31649946 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex breathlessness intervention
Number of subjects: 50
Study 31649946 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study 28588793 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Glutamine (10 g orally three times daily)
Number of subjects: 50
Study 28588793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 28588793 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Glutamine
Number of subjects: 50
Study 26109814 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous CD34(+) cell infusion
Number of subjects: 45
Study 26109814 — intervention group
Group type: COMPARATOR
Intervention: Standard of care treatment for liver cirrhosis
Number of subjects: 45
Study 24918558 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% E‐BPO
Number of subjects: 92
Study 24918558 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% E‐BPO
Number of subjects: 92
Study 24918558 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 92
Study 23063301 — intervention group
Group type: EXPERIMENTAL
Intervention: eszopiclone 1mg
Number of subjects: 72
Study 23063301 — intervention group
Group type: EXPERIMENTAL
Intervention: eszopiclone 2mg
Number of subjects: 72
Study 23063301 — intervention group
Group type: EXPERIMENTAL
Intervention: eszopiclone 3mg
Number of subjects: 72
Study 23063301 — intervention group
Group type: EXPERIMENTAL
Intervention: zolpidem 10mg
Number of subjects: 72
Study 23063301 — intervention group
Group type: EXPERIMENTAL
Intervention: eszopiclone (all doses)
Number of subjects: 72
Study 23063301 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study 19242916 — intervention group
Group type: EXPERIMENTAL
Intervention: Restorative yoga (RY) intervention (10 weekly 75-minute classes)
Number of subjects: 44
Study 19242916 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 44
Study 17603387 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigation system
Number of subjects: 20
Study 17603387 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography plan method
Number of subjects: 20
Study 17603387 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 20
Study 17603387 — intervention group
Group type: COMPARATOR
Intervention: Conventional method first
Number of subjects: 20
Study 17603387 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigation
Number of subjects: 20
Study 15007319 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular ketamine (0.5 mg/kg)
Number of subjects: 60
Study 15007319 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular neostigmine
Number of subjects: 60
Study 15007319 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular bupivacaine
Number of subjects: 60
Study 15007319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 11247525 — intervention group
Group type: EXPERIMENTAL
Intervention: Keys to Caregiving program delivered by 6-weekly visits
Number of subjects: 0
Study 11247525 — intervention group
Group type: COMPARATOR
Intervention: Control program consisting of 6-weekly neutral visits
Number of subjects: 0
Study 10868163 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulants
Number of subjects: 0
Study 10868163 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial treatments
Number of subjects: 0
Study 10868163 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term studies
Number of subjects: 0
Study 10868163 — intervention group
Group type: COMPARATOR
Intervention: Psychostimulants
Number of subjects: 0
Study 8021573 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 10-20 mg once daily for four weeks
Number of subjects: 17
Study 8021573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 2561594 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 10
Study 2561594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 779718 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofepramine
Number of subjects: 0
Study 779718 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study 31815726 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-ultrasound fusion imaging (n=7)
Number of subjects: 14
Study 31815726 — intervention group
Group type: COMPARATOR
Intervention: Traditional X-ray fluoroscopy (n=7)
Number of subjects: 14
Study 30783858 — intervention group
Group type: EXPERIMENTAL
Intervention: RENEW intervention (home-based diet and exercise)
Number of subjects: 641
Study 28236698 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL)
Number of subjects: 842
Study 25498151 — intervention group
Group type: EXPERIMENTAL
Intervention: MOOC (massive open online course)
Number of subjects: 48
Study 25498151 — intervention group
Group type: COMPARATOR
Intervention: Control group (self-paced online learning module)
Number of subjects: 48
Study 23740664 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT + surgery (4 sessions of topical PDT mediated with 20% 5-aminolevulinic acid)
Number of subjects: 13
Study 23740664 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 13
Study 22080019 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn
Number of subjects: 756
Study 22080019 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat
Number of subjects: 756
Study 22080019 — intervention group
Group type: EXPERIMENTAL
Intervention: Barley
Number of subjects: 756
Study 22080019 — intervention group
Group type: EXPERIMENTAL
Intervention: Lard
Number of subjects: 756
Study 22080019 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy oil
Number of subjects: 756
Study 22080019 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidulated vegetable soapstocks
Number of subjects: 756
Study 18648764 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycaemic index diet (Low-GI)
Number of subjects: 162
Study 18648764 — intervention group
Group type: COMPARATOR
Intervention: Low-carbohydrate/high-monounsaturated-fat diet (Low-CHO)
Number of subjects: 162
Study 18648764 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate/high-glycaemic index diet (High-GI)
Number of subjects: 162
Study 16152600 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid-based cytology (LBC)
Number of subjects: 5652
Study 16152600 — intervention group
Group type: COMPARATOR
Intervention: Conventional cytology
Number of subjects: 5652
Study 16117956 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily visits for 1 month
Number of subjects: 618
Study 16117956 — intervention group
Group type: COMPARATOR
Intervention: Weekly visits
Number of subjects: 618
Study 10851671 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed osteotomy using a cylindrical Shepard osteotome
Number of subjects: 52
Study 10851671 — intervention group
Group type: COMPARATOR
Intervention: Open osteotomy (control group)
Number of subjects: 52
Study 10851671 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed harvesting group
Number of subjects: 52
Study 10851671 — intervention group
Group type: COMPARATOR
Intervention: Open osteotomy group (control)
Number of subjects: 52
Study 10851671 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study 9199724 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal behavioural therapy (MBT)
Number of subjects: 35
Study 9199724 — intervention group
Group type: COMPARATOR
Intervention: Psychiatric treatment based on a psychodynamic approach (PT)
Number of subjects: 35
Study 1391144 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 30 mg/daily for two months
Number of subjects: 18
Study 1391144 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate 4 g/daily for two months
Number of subjects: 18
Study 3900900 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine (2 mg/kg/day) for 3 days
Number of subjects: 23
Study 3900900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 31599826 — intervention group
Group type: EXPERIMENTAL
Intervention: Plug-unplug catheter
Number of subjects: 90
Study 31599826 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous drainage catheter
Number of subjects: 90
Study 31599826 — intervention group
Group type: COMPARATOR
Intervention: Reference arm (discharged without a catheter)
Number of subjects: 90
Study 31599826 — intervention group
Group type: COMPARATOR
Intervention: Reference arm
Number of subjects: 90
Study 30063903 — intervention group
Group type: EXPERIMENTAL
Intervention: Loop electrosurgical excision procedure
Number of subjects: 182
Study 30063903 — intervention group
Group type: COMPARATOR
Intervention: Loop electrosurgical excision procedure–direct colposcopic vision
Number of subjects: 182
Study 27388807 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Navigation intervention promoting Fecal Occult Blood Test (FOBT) and complementary exams
Number of subjects: 0
Study 27388807 — intervention group
Group type: COMPARATOR
Intervention: Control group 1
Number of subjects: 0
Study 27388807 — intervention group
Group type: COMPARATOR
Intervention: Control group 2
Number of subjects: 0
Study 24681078 — intervention group
Group type: EXPERIMENTAL
Intervention: Sigmoidoscopy simulation
Number of subjects: 15566
Study 24681078 — intervention group
Group type: COMPARATOR
Intervention: Fecal immunochemical testing (FIT)
Number of subjects: 15566
Study 22196811 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumbo biopsy forceps
Number of subjects: 140
Study 22196811 — intervention group
Group type: COMPARATOR
Intervention: Standard biopsy forceps
Number of subjects: 140
Study 20174838 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncontiguous anterior decompression and fusion (NADF)
Number of subjects: 105
Study 20174838 — intervention group
Group type: COMPARATOR
Intervention: Contiguous corpectomies and fusion (CCF)
Number of subjects: 105
Study 18032997 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal lubricants (2 types of gels, suppositories) in addition to male and female condoms
Number of subjects: 301
Study 18032997 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 301
Study 18032997 — intervention group
Group type: COMPARATOR
Intervention: Group counseling
Number of subjects: 301
Study 18032997 — intervention group
Group type: COMPARATOR
Intervention: Individual counseling
Number of subjects: 301
Study 16446692 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy resistance training (RT)
Number of subjects: 17
Study 12169890 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgical simulator (ESS)
Number of subjects: 10
Study 10889127 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to use EMS during a witnessed cardiac event
Number of subjects: 962
Study 10889127 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual use of EMS
Number of subjects: 962
Study 10889127 — intervention group
Group type: COMPARATOR
Intervention: Non-EMS users' behaviors
Number of subjects: 962
Study 8744166 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold right unilateral (RUL) ECT
Number of subjects: 22
Study 8744166 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold bilateral (BL) ECT
Number of subjects: 22
Study 8744166 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.25 times threshold RUL ECT
Number of subjects: 22
Study 8744166 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.25 times threshold BL ECT
Number of subjects: 22
Study 8744166 — intervention group
Group type: COMPARATOR
Intervention: Control group (RUL ECT)
Number of subjects: 22
Study 1302744 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured psychosocial intervention (n = 13)
Number of subjects: 24
Study 1302744 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 11)
Number of subjects: 24
Study 3933197 — intervention group
Group type: EXPERIMENTAL
Intervention: Secretin (1 CU/Kg/h, 0 to 60 mins)
Number of subjects: 10
Study 3933197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystokinin (1 IU/Kg/h, 60 to 120 mins)
Number of subjects: 10
Study 3933197 — intervention group
Group type: COMPARATOR
Intervention: NaCl infusion (control group during crossover study)
Number of subjects: 10
Study 31002147 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet P (enriched-polyunsaturated fat hypocaloric diet)
Number of subjects: 363
Study 31002147 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet M (enriched-monounsaturated fat hypocaloric diet)
Number of subjects: 363
Study 31002147 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets (Diet P and Diet M)
Number of subjects: 363
Study 30254412 — intervention group
Group type: EXPERIMENTAL
Intervention: Clip-flap group (ESD using an endoclip)
Number of subjects: 104
Study 30254412 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (ESD without an endoclip)
Number of subjects: 104
Study 26343571 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin choice decision aid
Number of subjects: 168
Study 26343571 — intervention group
Group type: COMPARATOR
Intervention: Usual primary care
Number of subjects: 168
Study 23792625 — intervention group
Group type: EXPERIMENTAL
Intervention: cTnT levels ≥0.01 ng/ml
Number of subjects: 1041
Study 21885393 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity noninvasive positive pressure ventilation (Hi-NPPV)
Number of subjects: 15
Study 21885393 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity noninvasive positive pressure ventilation (Li-NPPV)
Number of subjects: 15
Study 21885393 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous breathing (SB)
Number of subjects: 15
Study 20070958 — intervention group
Group type: EXPERIMENTAL
Intervention: Three between-subject conditions differing in how the group outcome was computed from individual players' answers.
Number of subjects: 0
Study 20070958 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural Model (Chockler & Halpern, 2004)
Number of subjects: 0
Study 18538118 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 80 mg
Number of subjects: 67
Study 18538118 — intervention group
Group type: COMPARATOR
Intervention: Irbesartan 150 mg
Number of subjects: 67
Study 15870092 — intervention group
Group type: EXPERIMENTAL
Intervention: Community nurse follow-up
Number of subjects: 0
Study 15870092 — intervention group
Group type: COMPARATOR
Intervention: Physician-only follow-up
Number of subjects: 0
Study 15314987 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine (125 mg twice every 24h)
Number of subjects: 60
Study 15314987 — intervention group
Group type: COMPARATOR
Intervention: Control (no Ticlopidine)
Number of subjects: 60
Study 10229733 — intervention group
Group type: EXPERIMENTAL
Intervention: DCLHb (25, 50, and 100 mg/kg doses over 72 hours)
Number of subjects: 85
Study 10229733 — intervention group
Group type: EXPERIMENTAL
Intervention: DCLHb (100 mg/kg)
Number of subjects: 85
Study 10229733 — intervention group
Group type: EXPERIMENTAL
Intervention: DCLHb
Number of subjects: 85
Study 10229733 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 85
Study 8908453 — intervention group
Group type: EXPERIMENTAL
Intervention: In situ cooling
Number of subjects: 20
Study 8908453 — intervention group
Group type: COMPARATOR
Intervention: Warm ischaemia
Number of subjects: 20
Study 29593022 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital at Home care
Number of subjects: 0
Study 29593022 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital care
Number of subjects: 0
Study 25795013 — intervention group
Group type: EXPERIMENTAL
Intervention: LifeSkills Training (LST) + Strengthening Families Program: For Parents and Youth 10-14 (SFP 10-14)
Number of subjects: 670
Study 25795013 — intervention group
Group type: EXPERIMENTAL
Intervention: LifeSkills Training (LST) only
Number of subjects: 670
Study 25795013 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 670
Study 25561787 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable stent (BS)
Number of subjects: 17
Study 25561787 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic dilatation (ED)
Number of subjects: 17
Study 22031525 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI) and Waist to Hip Ratio (WHR)
Number of subjects: 141652
Study 22031525 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist
Number of subjects: 141652
Study 22031525 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist to Height Ratio
Number of subjects: 141652
Study 22031525 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiposity measures
Number of subjects: 141652
Study 20643002 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure system (LS)
Number of subjects: 28
Study 20643002 — intervention group
Group type: COMPARATOR
Intervention: Conventional titanium clips and surgical ties (CLTs)
Number of subjects: 28
Study 17571284 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 25 mg
Number of subjects: 10
Study 17571284 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 50 mg
Number of subjects: 10
Study 17571284 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 10
Study 17571284 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 200 mg
Number of subjects: 10
Study 17571284 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 400 mg
Number of subjects: 10
Study 17571284 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 25-400 mg
Number of subjects: 10
Study 16392413 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month exercise program based on dance (n = 20)
Number of subjects: 40
Study 16392413 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 40
Study 16392413 — intervention group
Group type: COMPARATOR
Intervention: Comparison between exercise and control group
Number of subjects: 40
Study 16392413 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group satisfaction
Number of subjects: 40
Study 12057734 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional infertility group
Number of subjects: 142
Study 12057734 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional infertility group (men)
Number of subjects: 142
Study 12057734 — intervention group
Group type: COMPARATOR
Intervention: Control group (women)
Number of subjects: 142
Study 9707305 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg once daily for three days)
Number of subjects: 122
Study 9707305 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor (30 mg/kg divided into three daily doses for ten days)
Number of subjects: 122
Study 9707305 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 122
Study 9707305 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor
Number of subjects: 122
Study 9707305 — intervention group
Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 122
Study 8585766 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (650 mg every 4 h)
Number of subjects: 0
Study 8585766 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg every 4 h)
Number of subjects: 0
Study 8585766 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (40 mg per day)
Number of subjects: 0
Study 8585766 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen, Aspirin, and Prednisone (as a group)
Number of subjects: 0
Study 8585766 — intervention group
Group type: COMPARATOR
Intervention: Control (Interferon alone)
Number of subjects: 0
Study 2242782 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical human leukocyte alpha-interferon 10(6) IU/g
Number of subjects: 98
Study 2242782 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical human leukocyte alpha-interferon 10(4) IU/g
Number of subjects: 98
Study 2242782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 355958 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine mesylate (2.5 mg twice daily for 14 days postpartum)
Number of subjects: 26